Detection of PCR inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay.

Journal of Clinical Microbiology
R P VerkooyenH A Verbrugh

Abstract

To determine that susceptibility of AMPLICOR Chlamydia trachomatis PCR to inhibitory factors possibly present in cervical specimens, we obtained cervical specimens from 200 gynecology patients attending our outpatient clinic. The prevalence of C. trachomatis infection was 4.1%, as determined by cell culture. All AMPLICOR specimens were tested in one procedure as described by the manufacturer, and after the specimen was spiked with C. trachomatis, several other pretreatment protocols were used. Complete inhibition of the PCR was observed in 38 (19%) cervical specimens. Heat treatment at 95 degrees C, freeze-thawing, or 10-fold dilution of the samples reduced the initial inhibition to 9, 16, or 9%, respectively. A combination of heat treatment and 10-fold dilution reduced the inhibition to 4% of the samples. A second specimen type (swabs inoculated in 0.2 M sucrose phosphate buffer [2SP]) was also evaluated. A 10-fold dilution of the spiked 2SP specimen resulted in an inhibition rate of 6%, which was comparable to that obtained by centrifugation of the 2SP specimen prior to processing. Furthermore, it was shown that the inhibition was not correlated with blood contamination. Processing the specimens on the day of collection or th...Continue Reading

References

Nov 1, 1992·Journal of Clinical Microbiology·M J LoeffelholzE A Dragon
Mar 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T W WilliamsK R Rozee

❮ Previous
Next ❯

Citations

Jul 2, 2003·Journal of the European Academy of Dermatology and Venereology : JEADV·G BezoldR U Peter
Oct 19, 2004·Clinical Microbiology Reviews·Anthony W SolomonDavid C W Mabey
Aug 9, 2011·ISRN Obstetrics and Gynecology·April L Harkins, Erik Munson
Nov 25, 2003·Journal of Medical Virology·Jonas LefevreUNKNOWN Canadian Women's HIV Study Group
Oct 19, 2002·Memórias do Instituto Oswaldo Cruz·Pamela CribbEsteban Serra
Oct 15, 2005·Clinical Microbiology Reviews·Daniel V LimMarianne F Kramer
Jul 26, 2002·Expert Review of Molecular Diagnostics·Barbara Van der Pol
Jun 2, 2000·Clinical Chemistry and Laboratory Medicine : CCLM·H J Burkardt
Sep 11, 2004·Journal of Medical Microbiology·Farida Hamdad-DaoudiFrançois Eb
Sep 28, 2001·Journal of Clinical Microbiology·B BöddinghausT Bittner
Jul 17, 1998·Journal of Clinical Microbiology·B ToyeK Ramotar
Feb 12, 1998·Journal of Clinical Microbiology·M RosenstrausJ P Spadoro
Apr 1, 1997·Journal of Clinical Microbiology·E M PetersonL M de la Maza
Mar 17, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Joeli A BrinkmanMichael E Hagensee
Jul 25, 2006·International Journal of Food Microbiology·Weimin Gu, Robert E Levin
Jan 27, 2006·The Journal of Molecular Diagnostics : JMD·David M WhileyTheo P Sloots
Sep 16, 2011·Forensic Science International. Genetics·Reza Alaeddini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.